The long-term objective of the T32 UCLA Interdepartmental Clinical Pharmacology Postdoctoral Training Program (ICPTP) is to produce clinical pharmacologists who have expertise in conceptualizing and implementing hypothesis driven, data based clinical pharmacology research;are competent clinically to achieve therapeutics of the highest quality;and are motivated to educate future clinical pharmacologists. The benchmarks of this successful program will be progress in clinical pharmacology research, improved therapeutic outcomes and decreased complication rates, all contributing to increased efficiency of the health care system. The diversity of the UCLA ICPTP has been confirmed both through the association of the David Geffen School of Medicine at UCLA with the Charles Drew University of Medicine and Science and by the specialties of the trainees, who have been MD or MD/PhD junior faculty with primary appointments in Anesthesiology/Critical Care Medicine, internal Medicine (Gastroenterology, Pulmonary, (Allergy/Immunology), Neurology, Obstetrics and Gynecology, Otolaryngology (Head and Neck Surgery), Pediatrics (Gastroenterology, Liver Transplantation, Immunotherapy, Pediatric Endocrinology), Psychiatry and Surgery (Liver Transplantation). This association and breadth of trainee areas of expertise broaden and enrich the T32 UCLA ICPTP curricular experience.
of the UCLA T32 Interdepartmental Clinical Pharmacology Postdoctoral Research Training Program resides in the outcomes or current activities of its graduates, the majority of whom are academicians. The clinical pharmacology skills of ICPTP alumnae translate to their activities as researchers, educators and clinicians, who serve as a nucleus to educate future clinical pharmacologists in diverse specialties, potentially resulting in declining medical errors in practice, hospitals and industry.
|Balan, Irina S; Saladino, Andrew J; Aarabi, Bizhan et al. (2013) Cellular alterations in human traumatic brain injury: changes in mitochondrial morphology reflect regional levels of injury severity. J Neurotrauma 30:367-81|
|Kristian, Tibor; Balan, Irina; Schuh, Rosemary et al. (2011) Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for neuroprotection. J Neurosci Res 89:1946-55|
|Hoang, Phuong T; Park, Patricia; Cobb, Laura J et al. (2010) The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice. Metabolism 59:343-9|
|Balan, Irina S; Fiskum, Gary; Kristian, Tibor (2010) Visualization and quantification of NAD(H) in brain sections by a novel histo-enzymatic nitrotetrazolium blue staining technique. Brain Res 1316:112-9|